Vascular 2023 – October 25 to 29 at the Palais des congrès de Montréal Six host organizations and five conferences for the price of one! This five-day event is your opportunity to address challenges related to patient care and the treatment of vascular-related diseases, which affect millions of Canadians annually. Together, we will promote the many benefits of a truly connected Canadian vascular…
Founded over 25 years ago, the Anticoagulation Forum (AC Forum) is the largest peer organization of anticoagulant service providers in North America.
Blog du Dr Jean-Pierre LAROCHE, médecin vasculaire sans filtre et pragmatique qui parle de Médecine Vasculaire et de l’actualité
The Claire McLintock Memorial Award In honor of Claire McLintock, M.… Luke Blount needs your support for Support Women’s Health in Memory of Claire McLintock
Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability
Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability
The Investor Relations website contains information about Cyclacel Pharmaceuticals, Inc.’s business for stockholders, potential investors, and financial analysts.
Prothrombin time (PT) and its derivative international normalized ratio (INR) are frequently ordered to assess the coagulation system. Plasma transfusion to treat incidentally abnormal PT/INR…
Current Treatment Options in Oncology – Gastrointestinal cancers are a heterogenous group of cancers that share common risk factors with cardiovascular disease. Therapy for gastrointestinal…
Current Treatment Options in Oncology – Gastrointestinal cancers are a heterogenous group of cancers that share common risk factors with cardiovascular disease. Therapy for gastrointestinal…
Given the number of cases against corporate health insurers for violating their contractual obligations with Medicare, the issue is not whether there will be more,…
